Skip to content
10-K

Annual Report

AYALA PHARMACEUTICALS, INC.

0001493152-24-014822

← back to feed
Filed
Apr 16, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stock Issued FY 2023 · Dec 31, 2023 0.19 sh
Shares Diluted FY 2023 · Dec 31, 2023 6.02M sh
Shares Diluted FY 2023 · Dec 31, 2022 2.9M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$29.49M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$34.51M
Cash And Equivalents FY 2023 · Dec 31, 2023 $4.88M
Cash And Equivalents FY 2023 · Dec 31, 2022 $2.41M
Stockholders Equity FY 2023 · Dec 31, 2023 −$24.42M
Stockholders Equity FY 2023 · Dec 31, 2022 −$1.1M
Stockholders Equity FY 2023 · Dec 31, 2021 $34.16M
Current Liabilities FY 2023 · Dec 31, 2023 $25.02M
Current Liabilities FY 2023 · Dec 31, 2022 $6.2M
Current Assets FY 2023 · Dec 31, 2023 $7.53M
Current Assets FY 2023 · Dec 31, 2022 $3.19M
Total Assets FY 2023 · Dec 31, 2023 $16.58M
Total Assets FY 2023 · Dec 31, 2022 $7.77M
Eps Diluted FY 2023 · Dec 31, 2023 −$7.99
Eps Diluted FY 2023 · Dec 31, 2022 −$13.13
Eps Basic FY 2023 · Dec 31, 2023 −$7.99
Eps Basic FY 2023 · Dec 31, 2022 −$13.13
Sga Expense FY 2023 · Dec 31, 2023 $12.19M
Sga Expense FY 2023 · Dec 31, 2022 $9.74M
Rd Expense FY 2023 · Dec 31, 2023 $24.08M
Rd Expense FY 2023 · Dec 31, 2022 $27.85M
Net Income FY 2023 · Dec 31, 2023 −$48.07M
Net Income FY 2023 · Dec 31, 2022 −$38.01M
Operating Income FY 2023 · Dec 31, 2023 −$36.27M
Operating Income FY 2023 · Dec 31, 2022 −$37.5M
Cost Of Revenue FY 2023 · Dec 31, 2023 $13K
Cost Of Revenue FY 2023 · Dec 31, 2022 $602K
Gross Profit FY 2023 · Dec 31, 2022 $90K